FDA Stakeholders Meeting For Chronic Fatigue Syndrome II: Barriers, Breakthroughs and Possibilities For Drug Development
“What we need in CFS is what I call the development of an innovation supply chain.” Bernard Munos started off Day II of the FDA Stakeholders Meeting on Chronic fatigue syndrome (ME/CFS). Bernard Munos is not an FDA guy – he’s an independent...StudyME
Enroll in the StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.